Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LSAMP-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DIAPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C15orf41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HS6ST3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FERMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAP1L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5AR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927933 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAN2C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFHR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP6D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on